Published in Mutat Res on June 01, 1992
Antimutagenic compounds and their possible mechanisms of action. J Appl Genet (2014) 0.83
The correlation between antimutagenic activity and total phenolic content of extracts of 31 plant species with high antioxidant activity. BMC Complement Altern Med (2016) 0.75
The influence of organic solvents on estimates of genotoxicity and antigenotoxicity in the SOS chromotest. Genet Mol Biol (2012) 0.75
Isolation and characterization of the compounds responsible for the antimutagenic activity of Combretum microphyllum (Combretaceae) leaf extracts. BMC Complement Altern Med (2017) 0.75
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Genotoxicity of chromium compounds. A review. Mutat Res (1990) 1.68
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Distribution of MR-induced sex-linked recessive lethal mutations in Drosophila melanogaster. Mutat Res (1985) 1.18
Chemopreventive properties and mechanisms of N-Acetylcysteine. The experimental background. J Cell Biochem Suppl (1995) 1.11
Is there a proportionality between the spontaneous and the X-ray-induction rates of mutations? Experiments with mutations at 13 X-chromosome loci in Drosophila melanogaster. Mutat Res (1979) 1.07
Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J (1997) 1.01
Molecular epidemiology of atherosclerosis. FASEB J (1997) 1.00
Genetic effects of PR toxin in eukaryotic microorganisms. Environ Mutagen (1979) 0.98
Studies on non-disjunction of the major autosomes in Drosophila melanogaster. I. Methodology and rate of induction by x-rays for the compound second chromosome. Mutat Res (1973) 0.98
Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res (1988) 0.97
Studies of non-disjunction of the major autosomes in Drosophila melanogaster. II. Effects of dose-fractionation, low radiation doses, EMS, and ageing. Mutat Res (1979) 0.95
Some problems associated with the testing for environmental mutagens and a perspective for studies in "comparative mutagenesis". Mutat Res (1977) 0.94
Modification of MR mutator activity in repair-deficient strains of Drosophila melanogaster. Mutat Res (1981) 0.93
The advantages of drosophila for mutation studies. Mutat Res (1974) 0.92
Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer (1996) 0.92
Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis (1989) 0.88
Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics (2001) 0.86
Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae. Mutat Res (2004) 0.86
Genotoxic, carcinogenic, and teratogenic hazards in the marine environment, with special reference to the Mediterranean Sea. Mutat Res (1991) 0.84
Metabolic reduction of chromium, as related to its carcinogenic properties. Biol Trace Elem Res (1990) 0.84
Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med (1991) 0.84
A study of the causes underlying the differences in radiosensitivity between mature spermatozoa and late spermatids in Drosophila. Mutat Res (1969) 0.84
Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84
Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats. Mutat Res (1991) 0.82
Photoactivation of mutagens. Carcinogenesis (1989) 0.82
Modulation of the mutagenic response in prokaryotes. Mutat Res (1992) 0.82
Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxide. Mutat Res (1976) 0.82
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Influence of the MR (mutator) factor on X-ray-induced genetic damage. Mutat Res (1981) 0.82
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82
The capacity of Drosophila for detecting relevant genetic damage. Mutat Res (1976) 0.81
The effect of multi-locus deletions in heterozygotes; a model study using Drosophila. Mutat Res (1990) 0.80
The inhibiting effect of caffeine on the maternal repair of radiation-induced chromosome breaks in Drosophila. Mutat Res (1974) 0.80
Genotoxic and mono-oxygenase system effects of the fungicide maneb. Arch Toxicol (2000) 0.80
Inhibition of the 'spontaneous' mutagenicity in Salmonella typhimurium TA102 and TA104. Mutat Res (1994) 0.80
A PHACES syndrome unmasked by propranolol interruption in a tetralogy of Fallot patient: case report and extensive review on new indications of beta blockers. Curr Med Chem (2014) 0.80
Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B. Environ Health Perspect (1994) 0.80
Development and application of biomarkers exploitable for human exposure monitoring. Teratog Carcinog Mutagen (1990) 0.80
Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems. Arch Toxicol (1980) 0.79
Cytochrome P-450 inducibility by ethanol and 7-ethoxycoumarin O-deethylation in S. cerevisiae. Biochem Biophys Res Commun (1984) 0.79
Induction of gene mutations and gene conversions by vinyl chloride metabolites in yeast. Cancer Res (1977) 0.79
Effects of cinnamaldehyde on survival and formation of HGPRT- mutants in V79 cells treated with methyl methanesulfonate, N-nitroso-N-methylurea, ethyl methanesulfonate and UV light. Mutat Res (1994) 0.78
The persistence of chromosome breaks in different stages of spermatogenesis of Drosophila. Mutat Res (1974) 0.78
Genotoxicity of mercury compounds. A review. Mutat Res (1994) 0.78
Biochemical and genetic interactions of two commercial pesticides with the monooxygenase system and chlorophyllin. J Environ Pathol Toxicol Oncol (1996) 0.78
Mutagenicity of active oxygen species in bacteria and its enzymatic or chemical inhibition. Mutat Res (1989) 0.78
Evaluation of the genetic effects induced by vinyl chloride monomer (VCM) under mammalian metabolic activation: studies in vitro and in vivo. Mutat Res (1976) 0.77
[Mutagenicity testing with Drosophila as a method for detecting potential carcinogens]. Biol Zent Bl (1980) 0.77
Mechanistic aspects of chromium carcinogenicity. Arch Toxicol Suppl (1989) 0.77
Structural basis of antimutagenicity of chemicals towards 4-nitroquinoline 1-oxide in Salmonella typhimurium. Mutagenesis (1994) 0.77
The use of different test systems with yeasts for the evaluation of chemically induced gene conversions and gene mutations. Mutat Res (1974) 0.77
Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest (2000) 0.77
Potent genotoxicity of halogen lamps, compared to fluorescent light and sunlight. Carcinogenesis (1990) 0.77
CYP superfamily perturbation by diflubenzuron or acephate in different tissues of CD1 mice. Food Chem Toxicol (2005) 0.77
Influence of DT diaphorase on the mutagenicity of organic and inorganic compounds. Carcinogenesis (1988) 0.77
Bacterial mutagenicity of cigarette smoke and its interaction with ethanol. Mutagenesis (1995) 0.77
Metabolic activation of food hepatocarcinogens in hepatitis B virus-infected humans and animals. Prog Clin Biol Res (1990) 0.76
Mutagenesis and carcinogenesis of halogenated ethylenes. Ann N Y Acad Sci (1988) 0.76
Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium. Teratog Carcinog Mutagen (1983) 0.76
The effects of treating Drosophila females with actinomycin-D on the yields of dominant lethals, translocations and recessive lethals recovered from X-irradiated spermatozoa. Mutat Res (1972) 0.76
Genetic and biochemical studies on perchloroethylene 'in vitro' and 'in vivo'. Mutat Res (1983) 0.76
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J (1996) 0.76
The effects of sodium fluoride and iodoacetamide on mutation induction by x-irradiation in mature spermatozoa of Drosophila. Mutat Res (1969) 0.76
Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials. J Cell Biochem Suppl (1996) 0.76
Genetic activity of vinylidene chloride in yeast. Mutat Res (1981) 0.76
Mutagenic activity and chemical analysis of airborne particulates collected in Pisa (Italy). Bull Environ Contam Toxicol (1994) 0.76
Problems and prospects in antimutagenesis and anticarcinogenesis. Mutat Res (1988) 0.76
Isolation of a novel metabolizing system enriched in phase-II enzymes for short-term genotoxicity bioassays. Mutat Res (1998) 0.76
Genotoxicity of vanadium compounds in yeast and cultured mammalian cells. Teratog Carcinog Mutagen (1991) 0.76
Diallyl sulfide inhibits the induction of HPRT-deficient mutants in Chinese hamster V79 cells treated with dimethylnitrosoamine in the presence of S-9 of rats induced with acetone. Environ Mol Mutagen (1995) 0.76
Cytochrome P-450 factors determining synthesis in strain D7 Saccharomyces cerevisiae. An alternative system to microsomal assay. Mutat Res (1983) 0.76
Mutagenicity of methyl methanesulfonate and cyclophosphamide in resting and growing Saccharomyces cerevisiae D7 cells. Mutat Res (1992) 0.76
Genetic and biochemical investigation on chloral hydrate in vitro and in vivo. Mutat Res (1984) 0.76
Assaying potential carcinogens with Drosophila. Environ Health Perspect (1976) 0.75
Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Cancer Epidemiol Biomarkers Prev (1993) 0.75
Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention. Basic Life Sci (1993) 0.75
Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. Environ Health Perspect (1993) 0.75
Classification of mechanisms of inhibitors of mutagenesis and carcinogenesis. Basic Life Sci (1990) 0.75
Neurocardiogenic syncope in selected pediatric patients--natural history during long-term follow-up and effect of prophylactic pharmacological therapy. Cardiovasc Drugs Ther (2001) 0.75
[Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up]. Cardiologia (1995) 0.75
Expression of cytochrome P450 in yeast after different chemical treatments. Carcinogenesis (1992) 0.75
Genetic and biochemical effects of dry residue of Arno river in vitro and in vivo. Bull Environ Contam Toxicol (1987) 0.75
Genotoxic and biochemical effects of dimethylamine. Mutagenesis (1993) 0.75
Effect of magnetic fields on rodent monooxygenase enzymes. Bioelectromagnetics (1995) 0.75
Mutagenicity and toxicity of electromagnetic fields. J Environ Pathol Toxicol Oncol (1994) 0.75
Comparative genetic activity of samples collected from two different urban waste incinerators. Bull Environ Contam Toxicol (1988) 0.75
The role of oxygen in determining initial radiosensitivity and post-radiation recovery in the successive stages of Drosophila spermatogenesis. Mutat Res (1965) 0.75
Effects of spermine on formation of HGPRT- mutants induced by ethylmethanesulfonate, methylmethanesulfonate, and mitomycin C in V79 Chinese hamster cells. Environ Mol Mutagen (1994) 0.75
Inhibition of yeast cytochrome P-450 by ammonium metavanadate. Mutat Res (1993) 0.75
NADPH as rate-limiting factor for microsomal metabolism. An alternative and economic NADPH-generating system for microsomal mono-oxygenase in in vitro genotoxicity studies. Mutat Res (1987) 0.75
Study of spermine and spermidine effects on Saccharomyces cerevisiae. Polyamine production in different growth conditions and in the presence of interleukin-2. J Environ Pathol Toxicol Oncol (1994) 0.75
Antimutagenic investigations on commercial yogurt. Basic Life Sci (1993) 0.75
Magnesium: its role in cellular functions--a review. J Environ Pathol Toxicol Oncol (1995) 0.75
EDTA affects cytochrome P450-dependent biotransformation reactions during incubations for the liver microsomal assay. Mutat Res (1988) 0.75
Induction of cytochrome P-450 by 5-methoxypsoralen in the yeast Saccharomyces cerevisiae. J Environ Pathol Toxicol Oncol (1994) 0.75
Influence of cinnamaldehyde on UV-induced gene conversion and point mutation in yeast: effect on protein synthesis. Mutat Res (1992) 0.75
Mycotic aneurysm of the thoracic aorta presenting as pneumonia. Pediatr Radiol (2001) 0.75
Stability of drug metabolizing enzymes during the incubation conditions of the liver microsomal assay with non-induced and induced mouse liver S-9 fractions. Carcinogenesis (1987) 0.75